Desk› Healthcare› Emcure Pharmaceuticals Ltd

Emcure Pharmaceuticals Ltd

BSE 544210 EMCURE INE168P01015

Healthcare Healthcare Pharmaceuticals & Biotechnology Pharmaceuticals NIFTY 500

Filing rhythm · 60 trading days

27 filings · 11 material · busiest 2026-08-06 and 2026-08-07

What it files

Analyst / Investor Meet8 Change in Management3 ESOP Allotment2 Investor Presentation2 Press Release2 Acquisition2 Newspaper Publication1 Board Outcome1

Filings

27 in the window

25 August 2026

ESOP Allotment

Allotment of ESOP / ESPS

Allotment of 19,100 Equity Shares pursuant to exercise of ESOPs under Emcure - Employee Stock Option Scheme 2013

Company Update / Allotment of ESOP / ESPS View filing →
12 August 2026

Analyst / Investor Meet

Analyst / Investor Meet - Outcome

Transcript of Earnings Call - Q1 FY27

Company Update / Analyst / Investor Meet View filing →
7 August 2026

Newspaper Publication

Newspaper Publication

Newspaper Publication of Unaudited Financial Results of the Company for the quarter ended June 30, 2026

Company Update / Newspaper Publication View filing →
7 August 2026

Analyst / Investor Meet

Analyst / Investor Meet - Intimation

Analyst/Investor Meet on Wednesday, August 12, 2026

Company Update / Analyst / Investor Meet View filing →
7 August 2026

Analyst / Investor Meet

Analyst / Investor Meet - Intimation

Analyst/ Investor Meet on Tuesday, August 18, 2026

Company Update / Analyst / Investor Meet View filing →
7 August 2026

Analyst / Investor Meet

Analyst / Investor Meet - Intimation

Analyst/ Investor Meet on Tuesday, September 01, 2026

Company Update / Analyst / Investor Meet View filing →
7 August 2026

Analyst / Investor Meet

Analyst / Investor Meet - Intimation

Analyst/ Investor Meet on Thursday, September 17, 2026

Company Update / Analyst / Investor Meet View filing →
7 August 2026

Analyst / Investor Meet

Analyst / Investor Meet - Intimation

Analyst/ Investor Meet on Tuesday, September 22, 2026

Company Update / Analyst / Investor Meet View filing →
6 August 2026

Board Outcome

Board Meeting Outcome for Outcome Of Board Meeting Held On August 06, 2026

Outcome of Board Meeting held on August 06, 2026

Board Meeting / Outcome of Board Meeting View filing →
6 August 2026

Results

Unaudited Financial Results (Standalone And Consolidated) For The Quarter Ended June 30, 2026

Unaudited Financial Results (Standalone and consolidated) for the quarter ended June 30, 2026

Result / Financial Results View filing →
6 August 2026

Investor Presentation

Investor Presentation

Presentation on Unaudited Financial Results for the quarter ended June 30, 2026

Company Update / Investor Presentation View filing →
6 August 2026

Change in Management

Change in Management

Intimation under Regulation 30 of the SEBI (LODR) Regulations, 2015 - Change in composition of the Board of the Company

Company Update / Change in Management View filing →
6 August 2026

Record Date

Intimation Of Date Of The 45Th Annual General Meeting And Record Date

Intimation of date of the 45th Annual General Meeting and Record Date for payment of Final Dividend on Equity Shares for the Financial Year March 31, 2026

Corp. Action / Record Date View filing →
6 August 2026

Analyst / Investor Meet

Analyst / Investor Meet - Outcome

Audio recording of Earnings Call - Q1 FY27

Company Update / Analyst / Investor Meet View filing →
22 July 2026

General

Intimation Under Regulation 30 Of The SEBI (Listing Obligations And Disclosure Requirements) Regulations, 2015 - Update On Completion Of Acquisition Of Shares Of Gennova Biopharmaceuticals Limited.

Update on completion of acquisition of shares of Gennova Biopharmaceuticals Limited

Company Update / General View filing →
21 July 2026

Change in Management

Change in Management

Intimation under Regulation 30 of the SEBI (LODR) Regulations, 2015 - Completion of 2nd term of Independent Director

Company Update / Change in Management View filing →
20 July 2026

Press Release

Press Release / Media Release

Press Release titled "Emcure to Expand the Use of Poviztra for MASH Indication Following CDSCO Approval".

Company Update / Press Release / Media Release View filing →
15 July 2026

Board Meeting

Board Meeting Intimation for Board Meeting Intimation For Approval Of Unaudited Financial Results (Standalone And Consolidated) For The Quarter Ended June 30, 2026

Emcure Pharmaceuticals Ltd has informed BSE that the meeting of the Board of Directors of the Company is scheduled on 06/08/2026 ,inter alia, to consider and approve Unaudited Financial ....

Board Meeting / Board Meeting View filing →
15 July 2026

Analyst / Investor Meet

Analyst / Investor Meet - Intimation

Intimation for Earnings Call - Q1 FY27

Company Update / Analyst / Investor Meet View filing →
13 July 2026

Acquisition

Acquisition

Intimation under Regulation 30 of SEBI (Listing Obligations and Disclosure Requirements) Regulations, 2015 - Acquisition

Company Update / Acquisition View filing →
13 July 2026

Press Release

Press Release / Media Release

Press Release titled - "Emcure Consolidates Gennova Ownership; Sharpens Focus on Biologics; Samit Mehta Leads the Next Phase of Growth"

Company Update / Press Release / Media Release View filing →
7 July 2026

Compliance Certificate

Compliances-Certificate under Reg. 74 (5) of SEBI (DP) Regulations, 2018

Confirmation under Regulation 74(5) of the SEBI (Depositories and Participants) Regulations, 2018, for the quarter ended June 30, 2026.

Company Update / Certificate under Reg. 74 (5) of SEBI (DP) Regulations, 2018 View filing →
3 July 2026

Acquisition

Acquisition

Intimation under Regulation 30 of SEBI (Listing Obligations and Disclosure Requirements) regulations, 2015 - Acquisition / Investment in step-down subsidiary by subsidiary

Company Update / Acquisition View filing →
30 June 2026

Change in Management

Change in Management

Intimation under Regulation 30 of the SEBI (Listing Obligations and Disclosure Requirements) Regulations, 2015 - Change in Senior Management Personnel of the Company

Company Update / Change in Management View filing →
29 June 2026

Trading Window

Closure of Trading Window

Intimation of Closure of Trading Window

Insider Trading / SAST / Closure of Trading Window View filing →
19 June 2026

ESOP Allotment

Allotment of ESOP / ESPS

Allotment of 20,600 Equity Shares pursuant to exercise of ESOPs under Emcure - Employee Stock Option Scheme 2013

Company Update / Allotment of ESOP / ESPS View filing →
12 June 2026

Investor Presentation

Investor Presentation

Intimation under Regulation 30 of the SEBI (Listing Obligations and Disclosure Requirements) Regulations, 2015 - Investor Presentation - June 2026

Company Update / Investor Presentation View filing →